Impact of medical therapy on transurethral resection of the prostate: two decades of change

摘要: Objective • To examine how the introduction of medical therapy for symptomatic benign prostatic hyperplasia (BPH) might have changed indications, patient characteristics and outcomes in men undergoing transurethral resection prostate (TURP) over two decades (1988-2008). Patients methods All patients who underwent TURP BPH a geographically defined area at our institution 1988 (before BPH), 1998 (when was becoming an important 2008 primary first line BPH) were reviewed. We assessed total number TURPs, indications surgery, age, health status, weight resected tissue, pre- postoperative events/complications. Results There 60% decrease TURPs from to with moderate increase 2008. Failure not indication 1988, but least one 36% 87% 2008, respectively. substantial rise percentage (but or risk presenting acute chronic urinary retention (AUR CUR) time their (from 22.9% 42.9% 14.6% 39.3% AUR CUR, respectively). also preoperative hydronephrosis (1.3% 12.5% 1998, 7.1% 2008). Inpatient stays decreased 4.1 day 2.7 days 2.1 2008), discharged catheter increased 3.2% 28.6% Conclusions The increasing use as treatment has resulted dramatic which, turn, been associated apparent poor outcomes. However, actual (either experienced these progression events are probably related earlier removal hospital discharge. It appears that we performing on right patients.